Human immunodeficiency virus (HIV) vectors containing
reporter genes or selectable markers have proven useful in a wide variety of experimental applications. For example, they have been used to study HIV-1 envelope glycoprotein function (4, 16) , to test the effects of antiviral compounds (14) , and to study viral assembly (20) , integration, and regulatory gene function (7) . While for some studies, the use of replicationcompetent virus may be advantageous, quantitating the infectivity of HIV stocks typically requires an end point dilution assay. This assay is time-consuming and is subject to statistical fluctuation due to the small number of viruses used and to experimental error inherent in the dilution process. Viral infectivity can also be estimated by infecting cells and measuring the amount of virus produced over a period of 1 to 2 weeks. However, such measurements are subject to variability in both viral replication and viability of the cell culture; over the course of several rounds of replication, small differences in initial viral growth rate can be either magnified or diminished. Furthermore, it is difficult to determine the infectivity of replicationcompetent virus in a single round of viral replication. Generally, only a small amount of virus is produced by an infected culture shortly after infection, and this amount may not be distinguishable from input virus remaining in the culture and shed into the supernatant from cell surfaces.
Several HIV-1 reporter viruses and indicator cell lines have been developed to allow quantitation of HIV-1 infectivity. One type consists of an HIV genome containing in the nef position a gene for an enzyme such as luciferase (2, 3) or chloramphenicol acetyltransferase (7) . Infection of cells with such a reporter virus is measured by determining the amount of reporter gene product present in lysates of the cells by using the appropriate enzyme assay. This results in an estimation of the amount of HIV expression in a population but does not allow estimation of the number of cells infected by the virus. Other vectors contain a selectable marker gene such as gpt r (15) or hygro r (4). Cells infected with these viruses form colonies after 7 to 10 days of growth in selective medium. This allows for the quantitation of individual infectious events. Indicator cells, such as those of the MAGI system, have proven useful for rapidly quantitating HIV infectivity (10) . In this system, HeLa cells containing a Tat-dependent long terminal repeat-␤-galactosidase transcription unit are infected with HIV-1. Infectivity is then determined by counting the blue cells after incubating with ␤-galactosidase substrate.
We report here on a novel HIV-1 reporter vector, HIV-AP, that contains the gene for human placental alkaline phosphatase (HPAP). Cells infected with the virus stain an intense purple after incubating with alkaline phosphatase detection reagents, nitroblue tetrazolium chloride (NBT) and 5-bromo-4-chloro-3-indolylphosphate (BCIP). This vector combines several advantages of existing HIV-1 reporter viruses. HIV-AP infectivity can be accurately quantitated in a variety of cell lines and in primary cells, its use is technically straightforward, and background staining of uninfected cells is minimal. Infection of a single cell among a large number of uninfected cells can be easily detected. Because infection is detected only after expression of the reporter gene, input virus remaining in the culture is not measured. In addition, by staining infected cells with fluorescent alkaline phosphatase substrate, HIV-AP-infected cells can be counted and sorted by flow cytometry. We demonstrate here the use of HIV-AP to detect an alternative receptor for HIV entry that is present in a CD4
Ϫ cell line. This receptor allows for viral entry with an efficiency about 5% that of CD4.
The structure of HIV-AP. Fields-Berry et al. (6) have previously described the construction of the murine leukemia virus (MLV) vector pDAP, which expresses HPAP. They showed that cells infected with DAP virus could be directly visualized by the dark purple color that developed upon staining infected cells with NBT and BCIP. The staining appeared to be more intense and showed less cell-to-cell variability than that observed for cells infected with the MLV reporter virus contain-ing the ␤-galactosidase gene. On the basis of their results, we constructed an analogous HIV-1 vector, pHIV-AP (Fig. 1) , in which the HPAP gene is inserted into the nef gene of pNL4-3. Because it lies in the nef gene, HPAP presumably is expressed shortly after infection of cells with HIV-AP virus. To ensure that the virus is restricted to a single round of replication, a frameshift has been inserted in env.
Infection of different cell types with HIV-AP. Initially, we produced HIV-AP as an amphotropic pseudotype, HIV-AP-(ampho), capable of infecting a wide range of cells. HIV-AP virus stock was produced by cotransfecting 293 cells (3 ϫ 10 6 ) with 10 g each of HIV-AP and pSV-A-MLV-Env by the calcium phosphate method (11) (Fig. 1) . Culture medium was harvested 48 h later and passed through a 0.45-m-pore-size filter. Virus supernatants typically contained 0.4 to 0.8 g of p24 gag per ml as measured by enzyme-linked immunosorbent assay (Abbott Laboratories) and were aliquoted and frozen. Cells (5.0 ϫ 10 4 adherent cells or 1 ϫ 10 6 nonadherent cells) in six-well culture dishes were infected with HIV-AP (50 ng of p24 gag per ml) in 2 ml of medium containing 8 g of Polybrene per ml. After 2 h, virus was removed and replaced with fresh medium. The cells were stained for alkaline phosphatase activity 36 h postinfection, as previously described (6) . Adherent cells (HOS and NIH 3T3) were fixed in 2 ml of 2% paraformaldehyde-phosphate-buffered saline (PBS) for 10 min. The cells were heated to 65ЊC for 20 min and then incubated at room temperature for 2 h with 1 mg of NBT and 0.1 mg of BCIP per ml in buffer containing 100 mM Tris (pH 9.5), 100 mM NaCl, and 10 mM MgCl 2 . Nonadherent (MT4 and CEM) cells were washed in 2 ml of PBS twice and then incubated in NBT-BCIP for 2 h at room temperature. In some experiments, 0.24 mg of the alkaline phosphatase inhibitor levamisole (Sigma) per ml was added during staining but was not found to have a significant effect. Each of the HIV-AP(ampho)-infected cultures contained significant numbers of purple cells (Fig. 2) ) and were stained at increasing intervals postinfection (Fig. 3) . HOS cells are highly susceptible to infection with amphotropic pseudotypes of HIV-1 and produce high levels of viral products upon infection with HIV-1 (unpublished observations). As early as 12 h postinfection, very faint staining, particularly on cellular processes, was observed. Staining became obvious 24 h postinfection and became darker at 36 h. This time course is consistent with that of Nef, which is one of the first proteins expressed following integration (9) . These results also show that the staining was not due to carryover of HPAP present in the virus preparation itself, since this would have resulted in staining at the earliest time points. Furthermore, staining could not be attributed to activation of endogenous alkaline phosphatase upon HIV-AP infection, since cells infected with control HIV-1 were not stained (not shown).
To determine the range over which HIV-AP infectivity could be accurately quantitated, we infected HOS cells with increasing amounts of HIV-AP(ampho). In addition, we produced reporter virus bearing HIV-1 Env by cotransfecting 293 cells with pSV-HXB2-env and HIV-AP (Fig. 1) . Increasing amounts of this virus were used to infect CEM cells. The results showed that the viruses had similar infectivities on their respective cell types. Similar results were obtained for the two viruses (Fig. 4) . Over a 2-log range (1 to 100 ng of p24 
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Effect of Env on HIV-AP tropism. We next tested the effect of Env on HIV-AP tropism. HIV-AP viruses were prepared without Env or with amphotropic, ecotropic, T-cell-tropic (HXB2), or macrophage-tropic (SF162) Env (Fig. 1) . The viruses were then used to infect HOS, HOS-T4 (HOS cells stably expressing a transfected CD4 gene), HeLa, HeLa-T4, NIH 3T3, COS, CEM, and MT4 cells. The results showed that HIV-AP(ampho) infected all of the cells tested (Table 1) . HIV-AP(HXB2), as expected, efficiently infected only the CD4 ϩ cells (CEM, MT4, HOS-CD4, and HeLa-T4) (Table 1) . Surprisingly, HIV-AP(HXB2) also infected HOS cells, although with lowered efficiency (about 5% of the level of HOS-T4 and HeLa-T4 cells). It is unlikely that this finding could be explained by contamination of the virus preparation with pseudotypes bearing endogenous Env glycoproteins expressed by the transfected 293 cells, since HIV-AP produced without an Env expression vector was not infectious (Table 1) . Alternatively, HOS cells could express a small amount of CD4 or an uncharacterized, alternative receptor.
HIV-AP(SF162), which contains a macrophage-tropic Env, infected peripheral blood mononuclear cells with an efficiency similar to that of HIV-AP(ampho) but failed to infect HeLa, HeLa-T4, MT4, and CEM-T4 cells, even though three of these are human CD4 ϩ cell lines ( Table 1) . As with virus bearing the T-cell-tropic Env, HIV-AP(SF162) infected HOS and HOS-T4 cells with a low efficiency, further suggesting that these cells express an alternative receptor for HIV-1 entry. The failure of HIV-AP(SF162) to infect the human CD4 ϩ cells is likely to be due to an early block in the viral life cycle, most likely at the entry stage. While this result is not unexpected, in at least one case macrophage tropism appears to be controlled by Env at a late stage in the virus life cycle (12) .
Blocking with sCD4. Because HIV-AP is an experimental system for studying HIV infectivity, it was possible that it would not mimic some of the properties of wild-type HIV. To test the ability of HIV-AP to accurately reflect at least one well-known property of HIV, we measured the inhibition of HIV-AP infectivity by soluble-CD4 immunoglobulin (sCD4-Ig) (Fig. 5) . The results showed that, at a concentration of 0.1 mg/ml, sCD4-Ig inactivated 50% of the virus, a value consistent with earlier findings (18) . This suggests that in this assay HIV-AP accurately reflects the properties of replication-competent HIV.
Blocking with anti-CD4 and antibody. We next tested whether the apparent CD4-independent infectivity of HIV-AP(HXB2) could be attributed to small amounts of cell surface CD4. To do this, we tested whether Leu3a, an anti-CD4 antibody that prevents gp120 binding (17) (Table 2 ). This finding suggests that the infection of HOS cells was not due to small amounts of cell surface CD4. It also suggests that the alternative receptor is not expressed on CEM cells, since these were not infectable through the CD4-independent route. -T4 and HOS) were treated with Leu3a (10 g/ml) and incubated at 37ЊC for 30 min before infection, and Leu3a was present during the infection. sCD4-Ig (10 g/ml) was incubated with viruses at room temperature for 1 h before infection. To determine whether CD4-independent infection involves the CD4 binding site on gp120, HIV-AP(HXB2) was incubated with an inhibitory concentration of sCD4-Ig and used to infect the same three cell lines. The results showed that sCD4-Ig completely blocked infectivity of all three cell types ( Table 2) . CD4-independent infection is therefore mediated by gp120 and probably involves a binding site near or identical to the CD4 binding site. Neither sCD4-Ig nor Leu3a blocked infection by HIV-AP(A-MLV), showing the specificity of the two inhibitors.
, would block HIV-AP(HXB2) infection of HOS cells. The results showed that Leu3a failed to block infection of HOS cells but completely blocked infection of CEM cells and partially blocked infection of HOS-T4 cells
Similar findings concerning HOS cell infection and blocking have been previously reported by Tateno et al. (19) ; however, because those studies involved replication-competent virus, it was not possible to estimate the efficiency with which the cells could be infected or blocked with various inhibitors, nor was it possible to directly demonstrate infection of these cells. The existence of alternative receptors for HIV-1 entry has been suggested in several previous reports (1, 5, 8, 13) .
FACS assay of infected cells. To quantitate HIV-AP infectivity by flow cytometry, we infected CEM cells with HIV-AP(ampho) and stained them 36 h later with the fluorescent alkaline phosphatase substrate Vector Red. This allows for more rapid counting of infected cells and for quantitation of the alkaline phosphatase expression levels in each cell. After staining with this substrate, uninfected cells emit green light upon excitation with UV light while infected cells emit red light. This difference was confirmed by UV microscopy (Fig. 6) . Fluorescence-activated cell sorter (FACS) analysis of the infected CEM cells showed an approximately 10-fold increase in the red fluorescence of the infected cells (Fig. 6) . A small increase in fluorescence intensity of the uninfected cells compared with those in the uninfected control culture may be due to leakage of the red dye from the positive cells. Staining with less Vector Red decreased this background but also decreased the staining intensity of the infected cells. Statistical analysis of the FACS data showed a low rate of false positives, suggesting the feasibility of sorting for small numbers of infected cells in a population. In uninfected control cultures, 1 in 5,000 cells was detected as positive (data not shown).
The HIV-AP system provides a rapid and accurate determination of infectivity, has a low background, and can be used in a wide variety of cell types. The virus can be produced with HIV-AP is likely to be useful for a variety of applications. Because it is replication defective, it can be used to determine the effects of mutations on specific stages of the viral life cycle. In addition, it can be used to screen antiviral agents that block the early stages of the viral life cycle (reverse transcriptase inhibitors, integrase inhibitors, and nuclear transport inhibitors) or to evaluate monoclonal anti-Env antibodies. HIV-AP will also be useful for studying the function of the other viral gene products, such as Nef or other accessory gene products.
